Terminated OBSERVATIONAL NCT06290856

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Sponsor: Oslo University Hospital

Conditions Cholangiocarcinoma Metastatic Colorectal Cancer Pancreas Adenocarcinoma

Interventions Multiplex PCR-test for circulating tumor DNA

Updated 4 times since 2024 Last updated: Jan 27, 2026 Started: Jan 15, 2024 Primary completion: Jul 15, 2024 Completion: Jul 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The platform used for detecting ctDNA was not sensitive enough.

Other terminated trials from Oslo University Hospital

See all terminations from Oslo University Hospital

Other Cholangiocarcinoma trials with similar outcome

Browse all Cholangiocarcinoma trials

This observational or N/A phase trial investigates Cholangiocarcinoma and Metastatic Colorectal Cancer and is currently terminated or withdrawn. Oslo University Hospital leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Terminated

Status: Recruiting → Terminated
Sep 2024 — Feb 2026 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting

First recorded

Jan 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway